Vitamin D receptor genotypes, ultraviolet radiation exposure, and risk of non-hodgkin lymphoma

American Journal of Epidemiology

Volumn 173, Issue 1, 2011, Pages 48-54

  Smedby, Karin Ekström ^a   Eloranta, Sandra ^b   Duvefelt, Kristina ^a   Melbye, Mads ^c   Humphreys, Keith ^b   Hjalgrim, Henrik ^c   Chang, Ellen T ^d,e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STATENS SERUM INSTITUT   (Denmark)

^d NORTHERN CALIFORNIA CANCER CENTER   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

case control studies; lymphoma, follicular; lymphoma, non Hodgkin; lymphoma, T cell; polymorphism, single nucleotide; receptors, calcitriol; ultraviolet rays; vitamin D

Indexed keywords

VITAMIN D RECEPTOR;

COMPUTER SIMULATION; FREQUENCY ANALYSIS; GENOTYPE; HEALTH RISK; HETEROGENEITY; LOGISTICS; OCCUPATIONAL EXPOSURE; POLYMORPHISM; REGRESSION ANALYSIS; ULTRAVIOLET RADIATION; VITAMIN;

ADULT; AGED; ARTICLE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; RADIATION EXPOSURE; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGED; DENMARK; DNA; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENOTYPE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECEPTORS, CALCITRIOL; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 78650463583     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq340     Document Type: Article

References (21)

1. Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer. 2004;112(5):865-871.
2. Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst. 2005;97(3):199-209.
3. Weihkopf T, Becker N, Nieters A, et al. Sun exposure and malignant lymphoma: a population-based case-control study in Germany. Int J Cancer. 2007;120(11):2445-2451.
4. Boffetta P, Van Der Hel O, Kricker A, et al. Exposure to ultraviolet radiation and risk of malignant lymphoma and multiple myeloma- a multicentre European case-control study. Int J Epidemiol. 2008;37(5):1080-1094.
5. Grandin L, Orsi L, Troussard X, et al. UV radiation exposure, skin type and lymphoid malignancies: results of a French case-control study. Cancer Causes Control. 2008;19(3):305-315.
6. Egan KM, Sosman JA, Blot WJ. Sunlight and reduced risk of cancer: is the real story vitamin D. J Natl Cancer Inst. 2005; 97(3):161-163.
7. Polesel J, Talamini R, Montella M, et al. Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lym-phoma: an Italian case-control study. Ann Oncol. 2006;17(4): 713-718.
8. Lim U, Freedman DM, Hollis BW, et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lym-phoid cancers. Int J Cancer. 2009;124(4):979-986.
9. Erber E, Maskarinec G, Lim U, et al. Dietary vitamin D and risk of non-Hodgkin lymphoma: the Multiethnic Cohort. Br J Nutr. 2010;103(4):581-584.
10. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J Steroid Biochem Mol Biol. 2004;89-90(1-5): 187-193.
11. Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183(9): 5458-5467.
12. Jurutka PW, Whitfield GK, Hsieh JC, et al. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord. 2001;2(2):203-216.
13. Köstner K, Denzer N, Müller CS, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29(9): 3511-3536.
14. Fang Y, Van Meurs JB, d'Alesio A, et al. Promoter and 3#-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study. Am J Hum Genet. 2005;77(5):807-823.
15. Purdue MP, Lan Q, Kricker A, et al. Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma. Haematologica. 2007;92(8):1145-1146. (Pubitemid 350144227)
16. Purdue MP, Hartge P, Davis S, et al. Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lym-phoma. Cancer Causes Control. 2007;18(9):989-999.
17. Fernberg P, Chang ET, Duvefelt K, et al. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2010;21(5):759-769.
18. Clayton D, Chapman J, Cooper J. Use of unphased multilocus genotype data in indirect association studies. Genet Epidemiol. 2004;27(4):415-428.
19. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008;4(2):80-90.
20. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-156.
21. Cianferotti L, Cox M, Skorija K, et al. Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc Natl Acad Sci USA. 2007;104(22):9428-9433.